These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28008823)

  • 1. Saccharomyces boulardii improves humoral immune response to DNA vaccines against leptospirosis.
    Silveira MM; Conceição FR; Mendonça M; Moreira GMSG; Da Cunha CEP; Conrad NL; Oliveira PD; Hartwig DD; De Leon PMM; Moreira ÂN
    J Med Microbiol; 2017 Feb; 66(2):184-190. PubMed ID: 28008823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the immunogenicity of the leptospiral LipL32, LigAni, and LigBrep recombinant proteins in the sheep model.
    da Rosa MC; Martins G; Rocha BR; Correia L; Ferronato G; Lilenbaum W; Dellagostin OA
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():176-180. PubMed ID: 31300110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.
    Forster KM; Hartwig DD; Oliveira TL; Bacelo KL; Schuch R; Amaral MG; Dellagostin OA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):989-95. PubMed ID: 26676320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera.
    da Cunha CEP; Bettin EB; Bakry AFAAY; Seixas Neto ACP; Amaral MG; Dellagostin OA
    Vaccine; 2019 Mar; 37(13):1844-1852. PubMed ID: 30826147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against leptospira.
    Feng CY; Li QT; Zhang XY; Dong K; Hu BY; Guo XK
    Braz J Med Biol Res; 2009 Sep; 42(9):796-803. PubMed ID: 19649391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.
    Forster KM; Hartwig DD; Seixas FK; Bacelo KL; Amaral M; Hartleben CP; Dellagostin OA
    Clin Vaccine Immunol; 2013 May; 20(5):725-31. PubMed ID: 23486420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA nanovaccines prepared using LemA antigen protect Golden Syrian hamsters against Leptospira lethal infection.
    Oliveira TL; Bacelo KL; Forster KM; Ilha V; Rodrigues OE; Hartwig DD
    Mem Inst Oswaldo Cruz; 2020; 115():e190396. PubMed ID: 32321154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.
    Seixas FK; Fernandes CH; Hartwig DD; Conceição FR; Aleixo JA; Dellagostin OA
    Can J Microbiol; 2007 Apr; 53(4):472-9. PubMed ID: 17612601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate.
    Oliveira TL; Grassmann AA; Schuch RA; Seixas Neto AC; Mendonça M; Hartwig DD; McBride AJ; Dellagostin OA
    PLoS One; 2015; 10(11):e0142821. PubMed ID: 26588685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.
    Umthong S; Buaklin A; Jacquet A; Sangjun N; Kerdkaew R; Patarakul K; Palaga T
    J Microbiol Biotechnol; 2015 Apr; 25(4):526-36. PubMed ID: 25348693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LemA and Erp Y-like recombinant proteins from Leptospira interrogans protect hamsters from challenge using AddaVax™ as adjuvant.
    Oliveira TL; Schuch RA; Inda GR; Roloff BC; Neto ACPS; Amaral M; Dellagostin OA; Hartwig DD
    Vaccine; 2018 May; 36(19):2574-2580. PubMed ID: 29625765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response in hamsters immunised with a recombinant fragment of LigA from Leptospira interrogans, associated with carrier molecules.
    Oliveira TL; Bacelo KL; Schuch RA; Seixas FK; Collares T; Rodrigues OE; Vargas J; Nascimento RO; Dellagostin OA; Hartwig DD
    Mem Inst Oswaldo Cruz; 2016 Nov; 111(11):712-716. PubMed ID: 27759768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45.
    Vijayachari P; Vedhagiri K; Mallilankaraman K; Mathur PP; Sardesai NY; Weiner DB; Ugen KE; Muthumani K
    Hum Vaccin Immunother; 2015; 11(8):1945-53. PubMed ID: 26020621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination based on pyolysin co-immunized with IL-1β enhances host antibacterial immunity against Trueperella pyogenes infection.
    Huang T; Zhao K; Zhang Z; Tang C; Zhang X; Yue B
    Vaccine; 2016 Jun; 34(30):3469-77. PubMed ID: 27091688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines against leptospirosis: A literature review.
    Silveira MM; Oliveira TL; Schuch RA; McBride AJA; Dellagostin OA; Hartwig DD
    Vaccine; 2017 Oct; 35(42):5559-5567. PubMed ID: 28882437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters.
    Faisal SM; Yan W; Chen CS; Palaniappan RU; McDonough SP; Chang YF
    Vaccine; 2008 Jan; 26(2):277-87. PubMed ID: 18055070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the humoral immune response elicited by a commercial vaccine against bovine respiratory disease by Enterococcus faecalis CECT7121.
    Díaz AM; Almozni B; Molina MA; Sparo MD; Manghi MA; Canellada AM; Castro MS
    Benef Microbes; 2018 Jun; 9(4):553-562. PubMed ID: 29633631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effect of short-term supplementation with Bacillus toyonensis BCT-7112
    Santos FDS; Maubrigades LR; Gonçalves VS; Alves Ferreira MR; Brasil CL; Cunha RC; Conceição FR; Leite FPL
    Vet Immunol Immunopathol; 2021 Jul; 237():110272. PubMed ID: 34029878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.